Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia

Equality Impact Assessment (Guidance development) (PDF 186 KB)

Final appraisal determination

Final appraisal determination document (PDF 541 KB)

Committee papers (PDF 2.35 MB)

Draft guidance

Appraisal consultation document (PDF 503 KB)

Committee papers (PDF 11.87 MB)

Final matrix (MSWord 76 KB)

Final scope (PDF 132 KB)

Equality impact assessment - scoping (PDF 76 KB)

Draft scope for consultation (pre-referral) - November 2014 (PDF 111 KB)

Provisional matrix (pre-referral) - November 2014 (PDF 105 KB)